APA (7th ed.) Citation

WESTENFELDER, C., CHOWDHURY, S. S., & GOOCH, A. (2022). 841-P: Scientific Basis for the First-in-Human Trial of “Neo-Islet”–Mediated Functional Cure of T1DM: The Intraperitoneal Administration of “Neo-Islets,” 3-D Organoids of Allogeneic Islet and Mesenchymal Stromal Cells from Rodents, Dogs, and Humans Durably Cures. Diabetes (New York, N.Y.), 71(Supplement_1), . https://doi.org/10.2337/db22-841-P

Chicago Style (17th ed.) Citation

WESTENFELDER, CHRISTOF, SABIHA S. CHOWDHURY, and ANNA GOOCH. "841-P: Scientific Basis for the First-in-Human Trial of “Neo-Islet”–Mediated Functional Cure of T1DM: The Intraperitoneal Administration of “Neo-Islets,” 3-D Organoids of Allogeneic Islet and Mesenchymal Stromal Cells from Rodents, Dogs, and Humans Durably Cures." Diabetes (New York, N.Y.) 71, no. Supplement_1 (2022). https://doi.org/10.2337/db22-841-P.

MLA (9th ed.) Citation

WESTENFELDER, CHRISTOF, et al. "841-P: Scientific Basis for the First-in-Human Trial of “Neo-Islet”–Mediated Functional Cure of T1DM: The Intraperitoneal Administration of “Neo-Islets,” 3-D Organoids of Allogeneic Islet and Mesenchymal Stromal Cells from Rodents, Dogs, and Humans Durably Cures." Diabetes (New York, N.Y.), vol. 71, no. Supplement_1, 2022, https://doi.org/10.2337/db22-841-P.